AAAAAA

   
Results: 1-23 |
Results: 23
SAP: natural inhibitor or grand SLAM of T cell activation?
Authors: Nichols, KE Koretzky, GA June, CH
Citation: Ke. Nichols et al., SAP: natural inhibitor or grand SLAM of T cell activation?, NAT IMMUNOL, 2(8), 2001, pp. 665-666
Can't get any help? New approaches for adoptive immunotherapy of cancer
Authors: June, CH
Citation: Ch. June, Can't get any help? New approaches for adoptive immunotherapy of cancer, J IMMUNOTH, 24(5), 2001, pp. 389-391
ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement
Authors: Riley, JL Blair, PJ Musser, JT Abe, R Tezuka, K Tsuji, T June, CH
Citation: Jl. Riley et al., ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement, J IMMUNOL, 166(8), 2001, pp. 4943-4948
Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo
Authors: Harada, Y Tokushima, M Matsumoto, Y Ogawa, S Otsuka, M Hayashi, K Weiss, ED June, CH Abe, R
Citation: Y. Harada et al., Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo, J IMMUNOL, 166(6), 2001, pp. 3797-3803
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: Implications for autoimmunity
Authors: Hamad, ARA Srikrishnan, A Mirmonsef, P Broeren, CPM June, CH Pardoll, D Schneck, JP
Citation: Ara. Hamad et al., Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: Implications for autoimmunity, J EXP MED, 193(10), 2001, pp. 1113-1121
Novel role of phosphatidylinositol 3-kinase in CD28-mediated costimulation
Authors: Harada, Y Tanabe, E Watanabe, R Weiss, BD Matsumoto, A Ariga, H Koiwai, O Fukui, Y Kubo, M June, CH Abe, R
Citation: Y. Harada et al., Novel role of phosphatidylinositol 3-kinase in CD28-mediated costimulation, J BIOL CHEM, 276(12), 2001, pp. 9003-9008
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
Authors: Woo, EY Chu, CS Goletz, TJ Schlienger, K Yeh, H Coukos, G Rubin, SC Kaiser, LR June, CH
Citation: Ey. Woo et al., Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer, CANCER RES, 61(12), 2001, pp. 4766-4772
The CD28 T-cell costimulatory pathway: Pharmacologic inhibition and augmentation
Authors: June, CH Ledbetter, JA
Citation: Ch. June et Ja. Ledbetter, The CD28 T-cell costimulatory pathway: Pharmacologic inhibition and augmentation, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 383-400
Response differences between human CD4+ and CD8+ T-cells during CD28 costimulation: Implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging
Authors: Laux, I Khoshnan, A Tindell, C Bae, D Zhu, XM June, CH Effros, RB Nel, A
Citation: I. Laux et al., Response differences between human CD4+ and CD8+ T-cells during CD28 costimulation: Implications for immune cell-based therapies and studies related to the expansion of double-positive T-cells during aging, CLIN IMMUNO, 96(3), 2000, pp. 187-197
Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma
Authors: Shibuya, TY Wei, WZ Zormeier, M Ensley, J Sakr, W Mathog, RH Meleca, RJ Yoo, GH June, CH Levine, BL Lum, LG
Citation: Ty. Shibuya et al., Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma, ARCH OTOLAR, 126(4), 2000, pp. 473-479
Costimulation light: Activation of CD4(+) T cells with CD80 or CD86 ratherthan anti-CD28 leads to a Th2 cytokine profile
Authors: Broeren, CPM Gray, GS Carreno, BM June, CH
Citation: Cpm. Broeren et al., Costimulation light: Activation of CD4(+) T cells with CD80 or CD86 ratherthan anti-CD28 leads to a Th2 cytokine profile, J IMMUNOL, 165(12), 2000, pp. 6908-6914
CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
Authors: Blair, PJ Riley, JL Harlan, DM Abe, R Tadaki, DK Hoffmann, SC White, L Francomano, T Perfetto, SJ Kirk, AD June, CH
Citation: Pj. Blair et al., CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis, J EXP MED, 191(4), 2000, pp. 651-660
Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule
Authors: Riley, JL Schlienger, K Blair, PJ Carreno, B Craighead, N Kim, D Carroll, RG June, CH
Citation: Jl. Riley et al., Modulation of susceptibility to HIV-1 infection by the cytotoxic T lymphocyte antigen 4 costimulatory molecule, J EXP MED, 191(11), 2000, pp. 1987-1997
Prolonged survival and tissue trafficking following adoptive transfer of CD4 zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects
Authors: Mitsuyasu, RT Anton, PA Deeks, SG Scadden, DT Connick, E Downs, MT Bakker, A Roberts, MR June, CH Jalali, S Lin, AA Pennathur-Das, R Hege, KM
Citation: Rt. Mitsuyasu et al., Prolonged survival and tissue trafficking following adoptive transfer of CD4 zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects, BLOOD, 96(3), 2000, pp. 785-793
Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells
Authors: Schlienger, K Craighead, N Lee, KP Levine, BL June, CH
Citation: K. Schlienger et al., Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells, BLOOD, 96(10), 2000, pp. 3490-3498
T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer
Authors: Garlie, NK LeFever, AV Siebenlist, RE Levine, BL June, CH Lum, LG
Citation: Nk. Garlie et al., T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer, J IMMUNOTH, 22(4), 1999, pp. 336-345
Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4(+) and CD8(+) T cells
Authors: Kaushal, S Landay, AL Lederman, MM Connick, E Spritzler, J Kuritzkes, DR Kessler, H Levine, BL St Louis, DC June, CH
Citation: S. Kaushal et al., Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4(+) and CD8(+) T cells, CLIN IMMUNO, 92(1), 1999, pp. 14-24
Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma
Authors: Shibuya, TY Wei, WZ Zormeier, M Ensley, J Sakr, W Mathog, RH Meleca, RJ Yoo, G June, CH Levine, B Lum, LG
Citation: Ty. Shibuya et al., Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma, ARCH OTOLAR, 125(11), 1999, pp. 1229-1234
Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes
Authors: Liu, KB Schoonmaker, MM Levine, BL June, CH Hodes, RJ Weng, NP
Citation: Kb. Liu et al., Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes, P NAS US, 96(9), 1999, pp. 5147-5152
Blockade of CD28 during in vitro activation of encephalitogenic T cells orafter disease onset ameliorates experimental autoimmune encephalomyelitis
Authors: Perrin, PJ June, CH Maldonado, JH Ratts, RB Racke, MK
Citation: Pj. Perrin et al., Blockade of CD28 during in vitro activation of encephalitogenic T cells orafter disease onset ameliorates experimental autoimmune encephalomyelitis, J IMMUNOL, 163(3), 1999, pp. 1704-1710
Primary human CD4(+) T cells contain heterogeneous I kappa B kinase complexes: Role in activation of the IL-2 promoter
Authors: Khoshnan, A Kempiak, SJ Bennett, BL Bae, D Xu, WM Manning, AM June, CH Nel, AE
Citation: A. Khoshnan et al., Primary human CD4(+) T cells contain heterogeneous I kappa B kinase complexes: Role in activation of the IL-2 promoter, J IMMUNOL, 163(10), 1999, pp. 5444-5452
Evidence for distinct intracellular signaling pathways in CD34(+) progenitor to dendritic cell differentiation from a human cell line model
Authors: St Louis, DC Woodcock, JB Fransozo, G Blair, PJ Carlson, LM Murillo, M Wells, MR Williams, AJ Smoot, DS Kaushal, S Grimes, JL Harlan, DM Chute, JP June, CH Siebenlist, U Lee, KP
Citation: Dc. St Louis et al., Evidence for distinct intracellular signaling pathways in CD34(+) progenitor to dendritic cell differentiation from a human cell line model, J IMMUNOL, 162(6), 1999, pp. 3237-3248
4-1BB costimulation promotes human T cell adhesion to fibronectin
Authors: Kim, YJ Mantel, PL June, CH Kim, SH Kwon, BS
Citation: Yj. Kim et al., 4-1BB costimulation promotes human T cell adhesion to fibronectin, CELL IMMUN, 192(1), 1999, pp. 13-23
Risultati: 1-23 |